MiR-222 promotes proliferation, migration and invasion of lung adenocarcinoma cells by targeting ETS1.
暂无分享,去创建一个
H Liu | X-C Lu | Q Sun | C-W Jiang | Z-H Tan | L-Y Hou | H Dong | K Liu | G Sun | Y-J Liu | Y-Q Wang
[1] D. Dornan,et al. miR-221/222 Targets Adiponectin Receptor 1 to Promote the Epithelial-to-Mesenchymal Transition in Breast Cancer , 2013, PloS one.
[2] Hui-huang Lin,et al. 4-Nitroquinoline-1-oxide effects human lung adenocarcinoma A549 cells by regulating the expression of POLD4. , 2016, Biomedical reports.
[3] M. Wang,et al. Bioinformatics analysis of two microarray gene-expression data sets to select lung adenocarcinoma marker genes. , 2012, European review for medical and pharmacological sciences.
[4] R. Govindan,et al. Genomic alterations in lung adenocarcinoma. , 2015, The Lancet. Oncology.
[5] L. O’Driscoll,et al. Global analysis of serum microRNAs as potential biomarkers for lung adenocarcinoma , 2013, Cancer biology & therapy.
[6] K. Syrigos,et al. The VEGF pathway in lung cancer , 2013, Cancer Chemotherapy and Pharmacology.
[7] X. Zhao,et al. MiR-221 and miR-222 simultaneously target ARID1A and enhance proliferation and invasion of cervical cancer cells. , 2016, European review for medical and pharmacological sciences.
[8] J. Dittmer. The role of the transcription factor Ets1 in carcinoma. , 2015, Seminars in cancer biology.
[9] P. Pu,et al. MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN , 2010, BMC Cancer.
[10] Shengguang Ding,et al. MicroRNA-222 promotes human non-small cell lung cancer H460 growth by targeting p27. , 2015, International journal of clinical and experimental medicine.
[11] A. Jemal,et al. Cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.
[12] Alessandra Carè,et al. Constitutive activation of the ETS-1-miR-222 circuitry in metastatic melanoma , 2011, Pigment cell & melanoma research.
[13] Yang Di,et al. Elevated expression of tumor miR-222 in pancreatic cancer is associated with Ki67 and poor prognosis , 2013, Medical Oncology.
[14] Carlos Cordon-Cardo,et al. miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer. , 2012, The American journal of pathology.
[15] M. Mino‐Kenudson,et al. Tumor islands and spread through air spaces: Distinct patterns of invasion in lung adenocarcinoma , 2016, Pathology international.
[16] F. McCormick,et al. EGFR inhibition evokes innate drug resistance in lung cancer cells by preventing Akt activity and thus inactivating Ets-1 function , 2015, Proceedings of the National Academy of Sciences.
[17] Hyojin Kim,et al. Overview of clinicopathologic features of ALK-rearranged lung adenocarcinoma and current diagnostic testing for ALK rearrangement. , 2015, Translational lung cancer research.
[18] N. Raghavachari,et al. miR-222 contributes to sex-dimorphic cardiac eNOS expression via ets-1. , 2013, Physiological genomics.